One of the most promising and rapidly growing pharmaceutical market in West Africa

More than 120 pharma formulation manufacturing facilities

Growth rate of 12% annually

The estimated market size would be US$ million 717 (2011) ( US$ 600 million in 2007)

60 per cent of drug manufacturing in the ECOWAS (Economic Community of West African States) sub-region takes place in Nigeria, underlining the huge sub regional market

In 2009, WHO in collaboration with NAFDAC, developed Nigerian Good Manufacturing Practices (NGMP). Subsequently, training workshops were organised by WHO for both PMG-MAN and NAFDAC on this subject. The appropriate application of these principles will enhance local manufacturing standards and improve the quality of locally produced medicines.